Moore Paul Andrew

Officer · ZYME

As of 2026-09-16, Moore Paul Andrew has 20 Form 4 transactions on record across 1 company — 12 in the trailing 12 months.

Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.

Pattern in the record: open-market sales filed in January in multiple years since 2025 — a recurring calendar cadence, more consistent with scheduled activity than a one-off decision.

Reconstructed holdings

Direct: $1.7MIndirect: $0$1.7Mas of 2026-09-16
  • Direct $1.7M
  • Indirect $0
ZYMEdirect66,000 sh$1.7M

Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.

Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.

Trades by company

ZYME · 20 trades
2026-01-12: Sale, 9,560 sh ($217K)2026-01-12: Option exercise, 17,666 sh ($0)2026-01-12: Award / grant, 66,000 sh ($0)2026-01-12: Option exercise, 17,666 sh ($0)2026-01-12: Award / grant, 47,000 sh ($0)2026-01-12: Award / grant, 70,000 sh ($0)2026-01-05: Sale, 10,821 sh ($272K)2026-01-05: Sale, 9,289 sh ($233K)2026-01-05: Option exercise, 17,168 sh ($0)2026-01-05: Option exercise, 17,168 sh ($0)2026-01-05: Option exercise, 20,000 sh ($0)2026-01-05: Option exercise, 20,000 sh ($0)2025-01-10: Award / grant, 79,000 sh ($0)2025-01-10: Award / grant, 53,000 sh ($0)2025-01-06: Sale, 11,408 sh ($170K)2025-01-06: Sale, 9,792 sh ($146K)2025-01-06: Option exercise, 17,166 sh ($0)2025-01-06: Option exercise, 20,000 sh ($0)2025-01-06: Option exercise, 17,166 sh ($0)2025-01-06: Option exercise, 20,000 sh ($0)

Filing ledger

DateCompanyActionShares @ priceValueOwnership ΔOwned afterFiling
2026-01-12ZYMESale9,560 @ $22.67$217K−16.5% of holding48,497Form 4
2026-01-05ZYMESale10,821 @ $25.10$272K−21.1% of holding40,391Form 4
2026-01-05ZYMESale9,289 @ $25.10$233K−22.9% of holding31,212Form 4
2025-01-06ZYMESale11,408 @ $14.92$170K−32.8% of holding23,333Form 4
2025-01-06ZYMESale9,792 @ $14.92$146K−39.9% of holding14,741Form 4
15 award / exercise / gift records — not counted as purchases
DateCompanyActionSharesOwned afterFiling
2026-01-12ZYMEOption exercise17,66658,057Form 4
2026-01-12ZYMEAward / grant66,00066,000Form 4
2026-01-12ZYMEOption exercise17,66635,334Form 4
2026-01-12ZYMEAward / grant47,00047,000Form 4
2026-01-12ZYMEAward / grant70,00070,000Form 4
2026-01-05ZYMEOption exercise17,16840,501Form 4
2026-01-05ZYMEOption exercise17,1680Form 4
2026-01-05ZYMEOption exercise20,00020,000Form 4
2026-01-05ZYMEOption exercise20,00051,212Form 4
2025-01-10ZYMEAward / grant79,00079,000Form 4
2025-01-10ZYMEAward / grant53,00053,000Form 4
2025-01-06ZYMEOption exercise17,16624,533Form 4
2025-01-06ZYMEOption exercise20,00040,000Form 4
2025-01-06ZYMEOption exercise17,16617,168Form 4
2025-01-06ZYMEOption exercise20,00034,741Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.